---
schema_version: "secwatch.filing_event.v1"
accession: "0001935979-26-000060"
form_type: "8-K"
ticker: "BHVN"
cik: "0001935979"
company_name: "Biohaven Ltd."
filed_at: "2026-08-07T20:10:34+00:00"
generated_at: "2026-08-07T20:12:08.885063+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Biohaven appoints John Yetimoglu to board, effective Aug 6, 2026

## Summary
- John Yetimoglu appointed to Biohaven board effective Aug 6, 2026; term expires at 2027 annual meeting.
- Granted options with aggregate grant date fair value of $713,875; vest 25% on grant, 25% annually over 3 years.
- Receives $57,000 annual retainer for director and committee service; joins Nominating and Governance Committee.
- No family relationships or reportable transactions with company per Item 404(a).

## SEC filing metadata
- accession: 0001935979-26-000060
- form_type: 8-K
- ticker: BHVN
- cik: 0001935979
- company_name: Biohaven Ltd.
- filed_at: 2026-08-07T20:10:34+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1935979/000193597926000060/0001935979-26-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1935979/000193597926000060/bhvn-20260803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001935979-26-000060
- JSON: https://secwatch.observer/filing/0001935979-26-000060.json
- Plain text: https://secwatch.observer/filing/0001935979-26-000060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.